KGbio
Adelaide Geraldine has a Bachelor's degree in Biotechnology from Atma Jaya Catholic University of Indonesia. Adelaide has extensive experience in various laboratory assistant roles, focusing on topics such as biomolecular and microbial diversity, bioinformatics, environmental microbiology, microbiology, and biochemistry. Adelaide has worked at companies like KGbio, Shopee, and PT Anugerah Global Superintending. Currently, Adelaide holds a position at KGbio in New Product Planning & Market Access, as well as Business Development & Licensing. Adelaide's background showcases a strong foundation in biotechnology and laboratory work.
This person is not in the org chart
This person is not in any teams
KGbio
KGbio is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. The business model revolves around in-licensing novel biologics and select biosimilars in oncology and high-specialty therapeutic areas (typically pre-IND or early clinical stage), with the objective to out-license them in target geographies after finishing clinical development as well as regulatory and reimbursement approvals. Platforms of interest currently include Fc-fusion proteins, antibodies, bispecifics, ADCs, cell therapies and therapeutic vaccines. The company is backed by Asian pharma companies Kalbe (market cap US$5.5 billion) and Genexine (market cap US$1.3 billion) and US private equity giant General Atlantic (AUM US$ 78 billion).